CIK 0001427925
- Non-accelerated filer
- Smaller reporting company
TALPHERA, INC.
Sign in to watch- Ticker
- TLPH
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 412193603
- Phone
- +1 650-216-3500
- Business address
- 1850 GATEWAY DRIVE, SUITE 175, SAN MATEO, CA, 94404
- Former names
- ACELRX PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-06-16 | ADAMS ADRIAN Director | Grant or award | +7,500 | 186,250 | ||
| 2020-06-16 | ADAMS ADRIAN Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2020-06-16 | WAN MARK A Director | Grant or award | +7,500 | 11,250 | ||
| 2020-06-16 | WAN MARK A Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2020-06-15 | ADAMS ADRIAN Director | Purchase | +100,000 | $1.29 | $129K | 178,750 |
| 2020-06-15 | ADAMS ADRIAN Director | Purchase | −100,000 | $1.29 | $129K | 178,750 |
| 2020-06-15 | Angotti Vincent J. Chief Executive Officer | Purchase | +7,547 | $1.33 | $10K | 468,757 |
| 2020-02-11 | Dasu Badri N Chief Engineering Officer | Shares withheld for taxes | −5,613 | $1.71 | $10K | 157,654 |
| 2020-02-11 | Hamel Lawrence G Chief Development Officer | Shares withheld for taxes | −5,613 | $1.71 | $10K | 127,769 |
| 2020-02-11 | Palmer Pamela P Chief Medical Officer | Shares withheld for taxes | −7,924 | $1.71 | $14K | 604,983 |
| 2020-02-11 | ASADORIAN RAFFI Chief Financial Officer | Shares withheld for taxes | −7,924 | $1.71 | $14K | 188,765 |
| 2020-02-11 | Angotti Vincent J. Chief Executive Officer | Shares withheld for taxes | −23,052 | $1.71 | $39K | 452,892 |
| 2020-02-06 | Palmer Pamela P Chief Medical Officer | Grant or award | +68,750 | 612,907 | ||
| 2020-02-06 | Palmer Pamela P Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +137,500 | 137,500 | ||
| 2020-02-06 | Dasu Badri N Chief Engineering Officer | Grant or award | +50,000 | 163,267 | ||
| 2020-02-06 | Dasu Badri N Chief Engineering Officer | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2020-02-06 | Angotti Vincent J. Chief Executive Officer | Grant or award | +200,000 | 475,944 | ||
| 2020-02-06 | Angotti Vincent J. Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +400,000 | 400,000 | ||
| 2020-02-06 | ASADORIAN RAFFI Chief Financial Officer | Grant or award | +68,750 | 196,689 | ||
| 2020-02-06 | ASADORIAN RAFFI Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +137,500 | 137,500 |
Page 13 of 17 · 329 trades